Position in CPRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$20,919,402
-$57,591,853 QoQ
Shares Held
844,887
-74.9% QoQ
Ownership
0.690%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Fundsmith LLP holds $35,781,333 across 2 Biotechnology names. CPRX ranks #1 (58.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CPRX |
Catalyst Pharmaceuticals, Inc.
This page
|
844,887 | $20,919,402 | |
| 2 | ADMA |
Adma Biologics, Inc.
|
1,649,493 | $14,861,931 |
All Filings in CPRX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $20,919,402 | 844,887 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $78,511,255 | 3,363,807 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $66,266,997 | 3,363,807 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $58,787,166 | 2,709,086 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $52,168,394 | 2,151,274 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||